107 related articles for article (PubMed ID: 33890954)
21. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins.
Windram OP; Weber B; Jaffer MA; Rybicki EP; Shepherd DN; Varsani A
Arch Virol; 2008; 153(3):585-9. PubMed ID: 18175039
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus type 58 L1 virus-like particles purified by two-step chromatography elicit high levels of long-lasting neutralizing antibodies.
Xie X; Liu Y; Zhang T; Xu Y; Bao Q; Chen X; Liu H; Xu X
Arch Virol; 2013 Jan; 158(1):193-9. PubMed ID: 22965579
[TBL] [Abstract][Full Text] [Related]
23. Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients in Escherichia coli.
Hajmohammadi S; Rassi H
Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):181-5. PubMed ID: 27244269
[TBL] [Abstract][Full Text] [Related]
24. Co-assembly of HPV capsid proteins and aggregation-induced emission fluorogens for improved cell imaging.
Jing J; Xue YR; Liu YX; Xu B; Li HW; Liu L; Wu Y; Tian W
Nanoscale; 2020 Mar; 12(9):5501-5506. PubMed ID: 32091054
[TBL] [Abstract][Full Text] [Related]
25. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).
Mach H; Volkin DB; Troutman RD; Wang B; Luo Z; Jansen KU; Shi L
J Pharm Sci; 2006 Oct; 95(10):2195-206. PubMed ID: 16871523
[TBL] [Abstract][Full Text] [Related]
26. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic.
Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M
Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614
[TBL] [Abstract][Full Text] [Related]
28. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
[TBL] [Abstract][Full Text] [Related]
29. Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.
Xu Y; Wang Q; Han Y; Song G; Xu X
J Med Microbiol; 2007 Jul; 56(Pt 7):907-913. PubMed ID: 17577054
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Heino P; Dillner J; Schwartz S
Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
[TBL] [Abstract][Full Text] [Related]
31. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
[TBL] [Abstract][Full Text] [Related]
32. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
33. Visualization of discrete L1 oligomers in human papillomavirus 16 virus-like particles by gel electrophoresis with Coomassie staining.
Zhao Q; Guo HH; Wang Y; Washabaugh MW; Sitrin RD
J Virol Methods; 2005 Aug; 127(2):133-40. PubMed ID: 15894387
[TBL] [Abstract][Full Text] [Related]
34. [Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].
Yan C; Li S; Wang J; Wei M; Huang B; Zhuang Y; Li Z; Pan H; Zhang J; Xia N
Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1527-33. PubMed ID: 20112683
[TBL] [Abstract][Full Text] [Related]
35. Papillomavirus-like particle vaccines.
Schiller JT; Lowy DR
J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
[TBL] [Abstract][Full Text] [Related]
36. Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris.
Jiang Z; Tong G; Cai B; Xu Y; Lou J
Protein Expr Purif; 2011 Dec; 80(2):203-10. PubMed ID: 21821128
[TBL] [Abstract][Full Text] [Related]
37. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.
Monroy-García A; Gómez-Lim MA; Weiss-Steider B; Hernández-Montes J; Huerta-Yepez S; Rangel-Santiago JF; Santiago-Osorio E; Mora García Mde L
Arch Virol; 2014 Feb; 159(2):291-305. PubMed ID: 23990055
[TBL] [Abstract][Full Text] [Related]
38. Nanoscale assemblies of gigantic molecular {Mo154}-rings: (dimethyldioctadecylammonium)20[Mo154O462H8(H2O)70].
Akutagawa T; Jin R; Tunashima R; Noro S; Cronin L; Nakamura T
Langmuir; 2008 Jan; 24(1):231-8. PubMed ID: 18041852
[TBL] [Abstract][Full Text] [Related]
39. Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves.
Zahin M; Joh J; Khanal S; Husk A; Mason H; Warzecha H; Ghim SJ; Miller DM; Matoba N; Jenson AB
PLoS One; 2016; 11(8):e0160995. PubMed ID: 27518899
[TBL] [Abstract][Full Text] [Related]
40. [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli].
Xie M; Li S; Shen W; Li Z; Zhuang Y; Mo X; Gu Y; Wu T; Zhang J; Xia N
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1082-7. PubMed ID: 19835152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
